EVRY, France--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris: ALGBE) announces having reached, and even significantly surpassed, the first productivity objective of the isobutene process defined in the context of the “Investissements d’Avenir” financing. The ADEME defined this productivity objective to ensure that the first industrial pilot trials be successful.
